Effective Withdrawal Time and Adenoma Detection Rate
Prospective Evaluation of Artificial Intelligence-assisted Monitoring of Effective Withdrawal Time on Adenoma Detection
1 other identifier
observational
193
1 country
1
Brief Summary
This study prospectively evaluated the role of EWT versus SWT on adenoma detection rate (ADR) and other key quality metrics. In this prospective single-center study, patients undergoing colonoscopy were enrolled. EWT was calculated in real-time using an AI system with endoscopists blinded to the results. We performed multivariable analyses to assess the association of EWT and SWT with binary (e.g., ADR) and count outcomes (e.g., adenoma per colonoscopy \[APC\]), after adjusting for patient and procedural characteristics.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 20, 2023
CompletedFirst Posted
Study publicly available on registry
October 2, 2023
CompletedStudy Start
First participant enrolled
November 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2025
CompletedSeptember 10, 2025
September 1, 2025
11 months
September 20, 2023
September 3, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Adenoma detection rates
Adenoma detection rates
During the colonoscopy
Secondary Outcomes (7)
Polyp detection rate
During that colonoscopy
Serrated lesion detection rate
During colonoscopy
Advanced adenoma detection rate
During colonoscopy
Adenoma per colonoscopy
During colonoscopy
Polyp per colonoscopy
During colonoscopy
- +2 more secondary outcomes
Study Arms (1)
AI group
AI monitoring of effective withdrawal time
Interventions
Eligibility Criteria
All patient will be recruited in Queen Mary Hospital, Hong Kong, China
You may not qualify if:
- history of inflammatory bowel disease
- history of colorectal cancer
- previous bowel resection (apart from appendectomy)
- Peutz-Jeghers syndrome, familial adenomatous polyposis or other polyposis syndromes
- bleeding tendency or severe comorbid illnesses for which polypectomy is considered unsafe.
- Cecum could not be intubated for various reasons
- Poor bowel preparation with Boston Bowel Preparation Scale (BBPS) \< 6
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Queen Mary Hospital, the University of Hong Kong
Hong Kong, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ka Luen Thomas Lui
The University of Hong Kong
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Associate Professor
Study Record Dates
First Submitted
September 20, 2023
First Posted
October 2, 2023
Study Start
November 1, 2023
Primary Completion
September 30, 2024
Study Completion
January 31, 2025
Last Updated
September 10, 2025
Record last verified: 2025-09